However, the molecular mechanisms underlying the regulation of Arid5a in mesenchymal tumors remain unclear and these mechanisms will be interest in future studies, especially in targeting Arid5a for tumor immunotherapy. The gene discussed is ARID5A; the disease is mesenchymal cell neoplasm.